ISELIN, N.J.: Ephicacy has announced key leadership appointments aimed at strengthening its biometrics expertise and global delivery capabilities, reinforcing its strategic growth trajectory in clinical development services.
In a significant move, Ephicacy has appointed Jamie Powers, DrPH, as Senior Vice President of Biometrics. In this role, Powers will lead the company’s Project-Based Services (PBS) unit, which includes Data Management, Biostatistics, and Statistical Programming.
He will report directly to CEO Tara Gladwell. The appointment underscores Ephicacy’s continued focus on enhancing its biometrics and analytics offerings to meet evolving industry demands.
Simultaneously, Ephicacy has named Tyagrajan “Tyagi” Swaminathan as Head of India Operations and Vice President of Statistical Programming.
This dual role strengthens leadership within one of Ephicacy’s key global delivery hubs and highlights the company’s commitment to scaling its operations in India.
Also Read: CrowdStrike Positions Endpoint as Epicenter for AI Security with New Falcon Platform Innovations
Ephicacy: Investing in Expanding Biometrics and Analytics Capabilities
Commenting on the appointments, CEO Tara Gladwell said, “Jamie’s expertise in advanced analytics, real-world evidence, and biostatistics aligns strongly with the evolving needs of modern clinical trials. His cross-industry experience will help expand our biometrics capabilities and strengthen the value we deliver to clients.”
She added, “We are also pleased to appoint Tyagi as Head of India, recognizing his leadership in building high-performing teams and advancing our global delivery model.”
These strategic appointments reflect Ephicacy’s continued investment in expanding its biometrics and analytics capabilities, especially as demand grows for advanced statistical programming and data science in clinical development.
The company aims to leverage this expertise to deliver more efficient and data-driven outcomes for its clients.
Bringing over 23 years of experience, Jamie Powers joins Ephicacy with an extensive background spanning biostatistics, clinical analytics, artificial intelligence, and real-world evidence.
He has previously held leadership roles at IQVIA, SAS Institute, ConcertAI, and Takeda Pharmaceutical Company.
His professional experience blends classical biostatistics and biometrics delivery with applied work in AI, real-world evidence, and operational analytics.
Also Read: Martin Price Named VP Products at Affle to Lead 3i AI Platform Innovation
Sharing his perspective on joining the organization, Powers said, “I am excited to join Ephicacy at a time when data science and AI are transforming clinical development. I look forward to strengthening our biometrics capabilities, advancing more predictable and efficient trial execution, and helping our clients unlock greater value from their data.”
With these appointments, Ephicacy continues to position itself at the forefront of biometrics innovation, reinforcing its capabilities in delivering advanced analytics and statistical programming solutions to the global clinical research ecosystem.
